# Editorial: Antibody-mediated rejection

**Authors:** Ramsey R. Hachem, Thalachallour Mohanakumar

PMC · DOI: 10.3389/frtra.2024.1408225 · Frontiers in Transplantation · 2024-04-10

## Full-text entities

- **Genes:** HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, EDNRA (endothelin receptor type A) [NCBI Gene 1909] {aka ET-A, ETA, ETA-R, ETAR, ETRA, MFDA}, AGTR1 (angiotensin II receptor type 1) [NCBI Gene 185] {aka AG2S, AGTR1B, AT1, AT1AR, AT1B, AT1BR}
- **Diseases:** autoimmune (MESH:D001327), death (MESH:D003643), transplant vasculopathy (MESH:D000090122), gastroesophageal reflux (MESH:D005764), organ failure (MESH:D009102), CLAD (MESH:D000092122), restrictive allograft syndrome (MESH:D002313), AMR (MESH:D020274), ischemia (MESH:D007511), PGD (MESH:D055031), reperfusion injury (MESH:D015427)
- **Chemicals:** carfilzomib (MESH:C524865), daratumumab (MESH:C556306)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11235309/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC11235309/full.md

---
Source: https://tomesphere.com/paper/PMC11235309